Yanmin Chang
Yi Yao
Rong Ma
Zemin Wang
Junjie Hu
Yanqing Wu
Xingjun Jiang
Lulu Li
Gang Li
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 3Harvard Medical School, Boston, MA, United States
A Corrigendum on
Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
by Chang, Y., Yao, Y., Ma, R., Wang, Z., Hu, J., Wu, Y., et al. (2021). Front. Neurosci. 15:620176. doi: 10.3389/fnins.2021.620176
In the published article, there was an error in affiliation 1. Instead of “Tongji Medical College, Wuhan Union Hospital, Huazhong University of Science and Technology, Wuhan, China,” it should be “Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.”
Additionally, there was an error in affiliation 2. Instead of “Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,” it should be “Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.”
Lastly, the affiliation superscript was missing for author Gang Li. This author should be affiliated to affiliation 1—“Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Dl-3-n-butylphthalide, tau, P301S, cognitive deficits, neuroinflammation
Citation: Chang Y, Yao Y, Ma R, Wang Z, Hu J, Wu Y, Jiang X, Li L and Li G (2021) Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice. Front. Neurosci. 15:716049. doi: 10.3389/fnins.2021.716049
Received: 28 May 2021; Accepted: 01 June 2021;
Published: 25 June 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Chang, Yao, Ma, Wang, Hu, Wu, Jiang, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gang Li, Z2FuZ2xpMjAwOEBob3RtYWlsLmNvbQ==